APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251,901 | -57.1% | 6,622 | +2.6% | 0.02% | -56.6% |
| Q2 2023 | $587,777 | -57.5% | 6,452 | -69.2% | 0.05% | -61.0% |
| Q1 2023 | $1,383,445 | +43.1% | 20,974 | +12.2% | 0.14% | +36.0% |
| Q4 2022 | $966,512 | -25.8% | 18,691 | -1.9% | 0.10% | -24.8% |
| Q3 2022 | $1,302,000 | +72.0% | 19,058 | +13.9% | 0.13% | +75.0% |
| Q2 2022 | $757,000 | -10.2% | 16,739 | +0.9% | 0.08% | +5.6% |
| Q1 2022 | $843,000 | +8.2% | 16,583 | +0.7% | 0.07% | +14.3% |
| Q4 2021 | $779,000 | +45.6% | 16,473 | +1.5% | 0.06% | +31.2% |
| Q3 2021 | $535,000 | -62.2% | 16,228 | -27.5% | 0.05% | -63.1% |
| Q2 2021 | $1,414,000 | +47.8% | 22,378 | +0.4% | 0.13% | +38.3% |
| Q1 2021 | $957,000 | – | 22,299 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |